Smartphone Services for Stimulant Use Disorder
ConditionStimulant Use Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDynamiCare Health
About this trial
This study is testing two approaches to treating Stimulant Use Disorder, or problems with cocaine, crack, methamphetamine, etc. Stimulant Use Disorder is a national epidemic in the U.S. but there is no FDA-approved medication to treat it. There is a behavioral approach that has been found to be the most effective treatment for Stimulant Use Disorder, but this study is testing whether this can be delivered by a smartphone service, remotely, such as at home.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults who are at least 18 years old, speak/read English, have a smartphone, and who meet criteria for Stimulant Use Disorder, active or early remission. If being discharged to outpatient or intensive outpatient care, the patient is eligible.
Disqualifiers
Unwilling to authorize communication with any treatment provider(s), requiring acute detoxification from alcohol or opioids or residential or hospital treatment, or other obstacle to longitudinal participation in the study.
Currently pregnant
Trial design
Design model
Parallel
Treatments tested in this trial
Smartphone digital therapeutic system
DeviceThis intervention is composed of a smartphone app (Apple iOS or Android type) that prompts patients with Stimulant Use Disorder to (1) complete self-assessment questionnaires in the app about their health, health care needs and the services they receive and other health-related functions in life, (2) read educational modules about health and wellness and answer questions about these readings, (3) speak periodically with a Guide about their use of the app, and (4) take periodic saliva substance tests using video-selfies with their smartphone camera. The intervention includes testing and interviews with the study staff over a 12 month period. There is a follow-up period to measure the longer-term results at 15 months, as well.
Treatment groups
270 Participants
are divided into 2 treatment groupsGroup A: DynamiCare GroupExperimental treatment 1 intervention
Group B: Health & Wellness GroupSham comparator 1 intervention
Trial outcomes
Primary outcomes
1
Saliva drug test outcomes
We will measure if your saliva drug tests show any use of drugs.
Time frame
Testing will occur over a 15 month period.Secondary outcomes
1
Health outcomes
We will ask you whether or not you are in treatment, whatever healthcare services you use (such as Emergency Room visits, hospital stays), the ways in which you use the app, and about your health and other health functioning.
Time frame
Assessments will occur over a 15 month period.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
DynamiCare Health
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Source ClinicalTrials.gov